logo
Select company
Select metric
Ticker Information

Ticker

PRTA

Company Name

PROTHENA CORP PUBLIC LTD CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROTHENA CORP PUBLIC LTD CO - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRTA - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ -261.68M$ 11.93M0
3/31/2025$ -115.86M$ -25.56M0
12/31/2024$ -128.93M$ 353.86M0
9/30/2024$ -140.05M$ 426.35M0
6/30/2024$ -61.4M$ 506.39M0
3/31/2024$ -185.14M$ 703M0
12/31/2023$ -160.48M$ 839.42M0
9/30/2023$ -86.52M$ 1.21B0
6/30/2023$ -153.75M$ 2.9B0
3/31/2023$ -137.42M$ 3.02B0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for PROTHENA CORP PUBLIC LTD CO is calculated as follows: EV [ $ 259.79M ] / EBIT [ $ -102.75M ]
(=) EV/EBIT [ 0 ]

PRTA - Enterprise Value over EBIT, Last 5 years

12.51

Minimum

Mar 31, 2022

27.37

Maximum

Sep 30, 2021

18.31

Average

15.05

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32